Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.36 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.36 |
| ▸ | CASR known ✓ | P41180 | 1/20 | 0.36 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.34 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B known ✓ | P41595 | 1/20 | 0.34 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.31 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.31 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.31 |
| ▸ | WNT3A | P56704 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8526324 | 0.81 | CYP3A4 (0.39) | TDP1CYP3A4GABRA1GABRB2TSHR | |
| SCHEMBL5150512 | 0.81 | GABRA1 (0.42) | TDP1CYP3A4GABRA1GABRB2TSHR | |
| Hydrochloric Acid SCHEMBL10760883 | 0.80 | CNR2 (0.40) | TDP1CYP3A4CASR | |
| SCHEMBL11431192 | 0.78 | ACHE (0.39) | TDP1CYP3A4GABRA1GABRB2TSHR | |
| Hydrochloric Acid SCHEMBL9346395 | 0.78 | CNR2 (0.43) | — | |
| Hydrochloric Acid SCHEMBL1485770 | 0.78 | CNR2 (0.43) | — | |
| Hydrochloric Acid SCHEMBL11053875 | 0.78 | CNR2 (0.43) | — | |
| Hydrochloric Acid SCHEMBL8172128 | 0.78 | CNR2 (0.43) | — | |
| Hydrochloric Acid SCHEMBL456432 | 0.78 | CNR2 (0.43) | — | |
| Hydrochloric Acid SCHEMBL23886258 | 0.78 | TDP1 (0.44) | TDP1CYP3A4GABRA1GABRB2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234840-A | Quick-drying multipurpose cleaning and sanitizing compositions and methods of use thereof | 埃科莱布美国股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-11166458-B2 | Wet wipes comprising antimicrobial coating compositions | ALLIED BIOSCIENCE, INC. (US) | 2021-11-09 | — | — | US | claimed |
| CN-110628530-A | Cleaning compositions, methods of manufacture and uses thereof | 莫尔豪斯医学院 | 2019-12-31 | — | — | CN | claimed |
| US-20180243790-A1 | WET WIPES COMPRISING ANTIMICROBIAL COATING COMPOSITIONS | ALLIED BIOSCIENCE, INC. (US) | 2018-08-30 | — | — | US | claimed |
| US-8894907-B2 | Process of making a cleaning implement comprising functionally active fibers | THE CLOROX COMPANY (US) | 2014-11-25 | — | — | US | claimed |
| US-8242176-B2 | Biocidal aldehyde composition for oil and gas extraction | MARTIN HOWARD (US) | 2012-08-14 | — | — | US | claimed |
| US-8088829-B2 | Biocidal aldehyde composition | MARTIN HOWARD (US) | 2012-01-03 | — | — | US | claimed |
| US-20110060052-A1 | Biocidal aldehyde composition for oil and gas extraction | MARTIN HOWARD | 2011-03-10 | — | — | US | claimed |
| US-20110059027-A1 | Biocidal aldehyde composition | MARTIN HOWARD | 2011-03-10 | — | — | US | claimed |
| US-20100080993-A1 | Electrospun Functional Fibers | THE CLOROX COMPANY | 2010-04-01 | — | — | US | claimed |
| US-7179849-B2 | Antimicrobial compositions containing colloids of oligodynamic metals | C. R. BARD, INC. (US) | 2007-02-20 | — | — | US | claimed |
| US-6015836-A | Chemical disinfectant employing dual chain quaternary ammonium compounds with iodine | MARTIN HOWARD (US) | 2000-01-18 | — | — | US | claimed |
| US-5322856-A | Dual quaternary ammonium chloride, para-tert-amyl phenol, ortho-phenyl phenol, citric or acetic acid, sodium citrate, isopropyl or ethyl alcohol, triethanolamine hydrochloride and water | MARTIN HOWARD | 1994-06-21 | — | — | US | claimed |
| US-5152996-A | Moistened, flexible sheets of cellulose fibers | EASTMAN KODAK COMPANY (US) | 1992-10-06 | — | — | US | claimed |
| US-4336151-A | AN ETHYLENE OXIDE FATTY AMIDE ADDUCT, POLYOXYETHYLENE GLYCOL WITH WITHOUT LANOLIN MODIFIER, PROTEIN HYDROLYZATES, ALLANTOIN, OR HEXYLENE GLYCOL | AMERICAN CYANAMID COMPANY (US) | 1982-06-22 | — | — | US | claimed |
| US-4336152-A | MALTODEXTRIN ADDITIVE | AMERICAN CYANAMID COMPANY (US) | 1982-06-22 | — | — | US | claimed |
| CN-119875972-A | Methods and compositions for preventing microbial infection | 比奥普来克斯有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-117769588-B | Methods and reagents for enhancing chemiluminescent signals | 欧蒙医学实验诊断股份公司 | 2025-02-21 | — | — | CN | disclosed |
| US-4263278-A | APPLYING ANTIMICROBIAL EMBALMING FLUID CONTAINING QUATERNARY AMMONIUM HALIDES | CHEM-SERV, INC., 1701 NORTHWEST MADRID WAY, BOCA RATON, FL. 33432 A CORP. OF FL. | 1981-04-21 | — | — | US | disclosed |
| US-3970576-A | 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL, ETHOXYLATED ALCOHOL | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11166458-B2 | Wet wipes comprising antimicrobial coating compositions | WIZ, CUTA, WASHC4 | GABRA1 3495/4885GABRB2 3674/4885ACHE 1551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.